Stockscreener 앱 받기
1.04
8.77%
-0.10
시간 외 거래:
1.04
전일 마감가:
$1.14
열려 있는:
$1.09
하루 거래량:
272.51K
Relative Volume:
0.04
시가총액:
$6.06M
수익:
$14.64M
순이익/손실:
$-13.74M
주가수익비율:
-0.1431
EPS:
-7.27
순현금흐름:
$-5.04M
1주 성능:
-15.45%
1개월 성능:
-40.57%
6개월 성능:
+73.33%
1년 성능:
+76.27%
1일 변동 폭
$1.01
$1.14
1주일 범위
$0.9948
$1.41
52주 변동 폭
$0.46
$4.44
Novabay Pharmaceuticals Inc Stock (NBY) Company Profile
명칭
Novabay Pharmaceuticals Inc
전화
510-899-8800
주소
2000 Powell Street, Suite 1150, Emeryville, CA
NBY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NBY
Novabay Pharmaceuticals Inc
|
1.04 | 6.85M | 14.64M | -13.74M | -5.04M | -7.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
416.81 | 104.76B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.67 | 63.06B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
578.05 | 60.32B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
843.66 | 51.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
165.76 | 34.49B | 398.11M | -1.03B | -868.57M | -5.7032 |
Novabay Pharmaceuticals Inc Stock (NBY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2019-09-18 | 개시 | Ladenburg Thalmann | Buy |
| 2018-07-06 | 재확인 | H.C. Wainwright | Buy |
| 2017-11-15 | 재확인 | Laidlaw | Buy |
| 2017-06-05 | 개시 | ROTH Capital | Buy |
| 2017-03-27 | 개시 | Laidlaw | Buy |
| 2017-02-06 | 개시 | Rodman & Renshaw | Buy |
| 2016-03-07 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2015-12-14 | 재확인 | Maxim Group | Buy |
| 2015-04-30 | 재개 | Maxim Group | Buy |
| 2013-03-06 | 개시 | Ascendiant Capital Markets | Strong Buy |
| 2008-01-03 | 개시 | Dawson James | Speculative Buy |
모두보기
Novabay Pharmaceuticals Inc 주식(NBY)의 최신 뉴스
Is NovaBay Pharmaceuticals Inc. (B9P0) stock cheap by valuation metrics2025 Macro Impact & Fast Moving Market Watchlists - Trung tâm Dự báo KTTV quốc gia
Can NovaBay Pharmaceuticals Inc. recover in the next quarter2025 Trading Recap & AI Enhanced Trading Signals - newser.com
Why NovaBay Pharmaceuticals Inc. stock remains undervaluedProfit Target & Fast Momentum Stock Entry Tips - Trung tâm Dự báo KTTV quốc gia
How higher bond yields impact NovaBay Pharmaceuticals Inc. stockJuly 2025 WrapUp & Daily Profit Focused Screening - Trung tâm Dự báo KTTV quốc gia
Institutional scanner results for NovaBay Pharmaceuticals Inc.Entry Point & Safe Capital Investment Plans - newser.com
Custom strategy builders for tracking NovaBay Pharmaceuticals Inc.GDP Growth & Reliable Momentum Entry Alerts - newser.com
Is NovaBay Pharmaceuticals Inc. reversing from oversold territoryWeekly Profit Recap & Safe Entry Trade Reports - newser.com
Statistical indicators supporting NovaBay Pharmaceuticals Inc.’s strength2025 Top Gainers & Verified Short-Term Trading Plans - newser.com
What technical signals suggest for NovaBay Pharmaceuticals Inc. stockEarnings Recap Report & AI Based Buy and Sell Signals - newser.com
NovaBay Pharmaceuticals Inc. stock trendline breakdown2025 Performance Recap & Free Technical Confirmation Trade Alerts - newser.com
Why NovaBay Pharmaceuticals Inc. stock is popular among millennials2025 Historical Comparison & Risk Controlled Stock Pick Alerts - newser.com
Is NovaBay Pharmaceuticals Inc. stock attractive for retirement portfoliosJuly 2025 Opening Moves & Safe Entry Point Alerts - newser.com
Can NovaBay Pharmaceuticals Inc. (B9P0) stock beat analyst consensusQuarterly Growth Report & Technical Pattern Recognition Alerts - newser.com
Can NovaBay Pharmaceuticals Inc. stock hit analyst price targetsTrade Risk Assessment & Weekly Stock Performance Updates - newser.com
What institutional flow reveals about NovaBay Pharmaceuticals Inc.Market Sentiment Summary & Weekly Momentum Stock Picks - newser.com
NovaBay Pharmaceuticals CEO David Lazar to resign following stock transfer agreement - Investing.com Canada
Visual analytics tools that track NovaBay Pharmaceuticals Inc. performance2025 Geopolitical Influence & Community Consensus Trade Signals - newser.com
Published on: 2025-10-09 05:27:34 - newser.com
Using flow based indicators on NovaBay Pharmaceuticals Inc.Weekly Earnings Recap & Daily Risk Controlled Trade Plans - newser.com
Reviewing AngioSoma (OTCMKTS:SOAN) and NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) - Defense World
NovaBay Pharmaceuticals Inc Stock Analysis and ForecastPrice Volatility Patterns & Budget Friendly Portfolio Growth - earlytimes.in
Will NovaBay Pharmaceuticals Inc. (B9P0) stock outperform small cap peersMarket Rally & Weekly Market Pulse Updates - newser.com
Novabay Pharmaceuticals files for mixed shelf of up to $200 millionSEC filing - MarketScreener
How to read the order book for NovaBay Pharmaceuticals Inc.Weekly Volume Report & Weekly Market Pulse Updates - newser.com
What analysts say about NovaBay Pharmaceuticals Inc stockEarnings Miss Alerts & Low Cost Wealth Strategies - earlytimes.in
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
How NovaBay Pharmaceuticals Inc. (B9P0) stock reacts to monetary easingQuarterly Trade Review & High Accuracy Trade Alerts - newser.com
Novabay Pharmaceuticals Inc (NBY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.84%
0.50%
자본화:
|
볼륨(24시간):